Intervention Review

You have free access to this content

Intramuscular arteether for treating severe malaria

  1. Bosede B Afolabi1,*,
  2. Christy AN Okoromah2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 18 OCT 2004

Assessed as up-to-date: 26 OCT 2010

DOI: 10.1002/14651858.CD004391.pub2


How to Cite

Afolabi BB, Okoromah CAN. Intramuscular arteether for treating severe malaria. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004391. DOI: 10.1002/14651858.CD004391.pub2.

Author Information

  1. 1

    University of Lagos, Department of Obstetrics and Gynaecology, Lagos, Nigeria

  2. 2

    College of Medicine, University of Lagos, Department of Paediatrics and Child Health, Lagos, Lagos, Nigeria

*Bosede B Afolabi, Department of Obstetrics and Gynaecology, University of Lagos, College of Medicine, PMB 12003, Idi-Araba, Lagos, Nigeria. bosedeafolabi2003@yahoo.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 18 OCT 2004

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Renu Tripathi, Amber Rizvi, Swaroop Kumar Pandey, Hemlata Dwivedi, J.K. Saxena, Ketoconazole, a cytochrome P450 inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis, Acta Tropica, 2013, 126, 2, 150

    CrossRef

  2. You have free access to this content2
    David Sinclair, Sarah Donegan, Rachel Isba, David G Lalloo, Artesunate versus quinine for treating severe malaria, The Cochrane Library,
  3. You have free access to this content3
    David Sinclair, Sarah Donegan, David G Lalloo, Artesunate versus quinine for treating severe malaria, The Cochrane Library,